EXHIBIT 11
CYTOCLONAL PHARMACEUTICS INC.
COMPUTATION OF NET (LOSS) PER COMMON SHARE
(unaudited)
THREE MONTHS NINE MONTHS
ENDED SEPTEMBER 30, ENDED SEPTEMBER 30,
1998 1997 1998 1997
------------ ------------ ------------ ------------
Net (loss) $ (976,000) $ (945,000) $(1,935,000) $(2,462,000)
Add cumulative preferred dividend (48,000) (69,000) (143,000) (207,000)
------------ ------------ ------------ ------------
NET (LOSS) USED FOR COMPUTATION $(1,024,000) $(1,014,000) $(2,078,000) $(2,669,000)
Weighted average number of common
shares outstanding - basic and
diluted 10,172,000 8,261,000 9,585,000 8,136,000
------------ ------------ ------------ ------------
Net (loss) per common share -
basic and diluted $ (0.10) $ (0.12) $ (0.22) $ (0.33)
12